Verve Therapeutics VERV 深 沪
已收盘 07-25 16:00:00 美东时间
11.13
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 11.13
- 总市值 9.94亿
- 52周最高 11.405
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 2.8647
- 委 比 0.00%
- 总股本 8931.22万
- 历史最高 78.00
- 量 比 0
- 振 幅 0.00%
- 历史最低 2.8647
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Lilly says gene editing therapy cut “bad” cholesterol in early-stage trial
Eli Lilly (LLY) announced that its gene editing candidate VERVE-102, added from its $1.3B acquisition of Verve Therapeutics last year, caused up to a 62% average decline in low-density lipoprotein cho...
05-26 19:33
CAMP4 Appoints Michael MacLean to its Board of Directors
CAMP4 Therapeutics announced the appointment of Michael MacLean to its Board of Directors. With over 35 years of financial and operational leadership in biotechnology, MacLean brings extensive experience in growing innovative biotech companies. His expertise will support CAMP4 as it advances its CMP-002 program toward a Phase 1/2 clinical trial for SYNGAP1-related disorder, for which there are currently no approved treatments. MacLean previously ...
03-24 11:00
Verve Therapeutics Announces Merger and Nasdaq Delisting
Verve Therapeutics ( ($VERV) ) just unveiled an update. Verve Therapeutics has ...
2025-07-26 04:51
Eli Lilly And Verve Therapeutics Announces That The Tender Offer For All Outstanding Verve Shares, Priced At $10.50 Per Share In Cash Plus A Potential Additional $3.00 Via A Non-Tradable Contingent Value Right, Officially Expired At 12:01 A.M. Et On July 24, 2025. The Offer Was Not Extended.
Eli Lilly and Company (NYSE:LLY) and Verve Therapeutics, Inc. (NASDAQ:VERV) today announced that the tender offer to purchase all of the issued and outstanding shares ("Shares") of Verve's common stock in exchange for
2025-07-24 20:05
